Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia

Background/rationaleRomiplostim is a thrombopoietin receptor agonist recommended as a second-line therapy for immune thrombocytopenia. An initial dose of 1 mcg/kg/week subcutaneously with weekly 1 ...